期刊文献+

红花黄色素粉针与贝那普利联合治疗糖尿病肾病39例疗效观察 被引量:9

Effect of Treatment in 39 Patients with Diabetic Nephropathy by Safflor Yellow and Benazepril in Combination
下载PDF
导出
摘要 目的观察红花黄色素粉针与贝那普利(洛汀新)联合治疗糖尿病肾病(DN)的临床疗效。方法将76例DN患者随机分为治疗组39例和对照组37例,两组均予常规降糖治疗,贝那普利口服每次10mg,每日1次。治疗组另予红花黄色素粉针150mg加入生理盐水250mL静脉滴注,每日1次,15日为1个疗程,停用5日后开始第2个疗程,共2个疗程。观察两组临床症状、尿微量白蛋白排泄率(UAER)、血β2-微球蛋白(β2-MG)、尿β2-微球蛋白(β2-MG)、尿α1-微球蛋白(α1-MG)、D-二聚体(D-D)、血浆纤维蛋白原(FIB)变化。结果治疗组总有效率为84·6%,对照组总有效率为59·4%,两组比较差异有统计学意义(χ2=6·83,P<0·05)。治疗后治疗组与对照组比较,症状积分明显减少,差异有统计学意义(P<0·05)。治疗后两组UAER、血β2-MG、尿β2-MG、尿α1-MG均有所降低,与治疗前比较差异有统计学意义(P<0·05或P<0·01);且治疗组与对照组比较,差异有统计学意义(P<0·05);治疗后治疗组FIB、D-D显著下降,与治疗前及对照组比较,差异均有统计学意义(P<0·01),对照组治疗前后差异无统计学意义(P>0·05)。结论红花黄色素粉针与贝那普利联合应用治疗DN,在减少尿蛋白,改善肾功能,改善高凝状态方面明显优于单用贝那普利,提示两药合用在延缓DN进展方面能够发挥各自的优势,起到协同作用。 Objective To observe the clinical effect of combined treatment with safflor yellow powder injection and benazepril in treating patients with diabetic nephropathy (DN). Methods Seventy-six patients with DN were randomly assigned to the treatment group (39 cases) and the control group (37 cases). Conventional treatment for lowering blood glucose was given to both groups, but to the control group 10 mg benazepril was given orally once a day additionally, while to those in the treatment group the same dosage of benazepril po. and 150 mg/d of safflor yellow powder injection by adding in 250 mL 0. 9% normal saline for intravenous dripping. The therapeutic course for them all was 15 days, and all patients received two courses with an interval of 5 days. Changes of clinical symptoms, urinary albumin excretion rate ( UAER), blood and urinary levels of β2-microglobulin ( β2-MG), urinary level of α1-microglobulin ( α1-MG ), D-dimer ( D-D ) and plasma fibrinogen ( FIB ) were observed. Results The total effective rate in the treatment group was higher than that in the control group (84. 62% vs 59. 45%, P 〈0. 05). The total score of syndrome in the treatment group was lower than that in the control group (P 〈 0.05). Levels of UAER, β2-MG in serum and in urine, α1-MG in urine were decreased significantly after after 2 courses of treatment in both groups, showing significant difference as compared with before treatment (P 〈 0. 05 or P 〈0. 01 ), and the decrements were more significant in the treatment group than those in the control group (P 〈0. 05) ; while decrease of FIB, D-D only happened in the treatment group (P 〈0. 01 ) ,so the post-treatment data in the treatment group were significantly lower as compared with those in the control group (P 〈0. 01 ). Conclusion Combined therapy with safflor yellow injection and benazepril is superior to benazepril alone in reducing urinary albumin, improving renal function and blood hyperviscosity manner for patients with DN, suggesting the combination of the two could play their respective superiorities and act in cooperation for retarding the progression of DN.
出处 《中国中西医结合杂志》 CAS CSCD 北大核心 2008年第4期360-363,共4页 Chinese Journal of Integrated Traditional and Western Medicine
基金 河北省科技攻关课题(No.07276101D-111)
关键词 红花黄色素粉针 贝那普利 糖尿病肾病 safflor yellow powder injection benazepril diabetic nephropathy
  • 相关文献

参考文献10

二级参考文献53

  • 1王拥军,何士大.抗氧化中药的研究现状[J].中国中西医结合杂志,1996,16(5):312-314. 被引量:98
  • 2刘朝一,杨国邦,徐勇.糖尿病肾病的早期诊断:标志物和方法[J].国外医学(临床生物化学与检验学分册),1996,17(4):155-156. 被引量:14
  • 3Okada S, Shikata K, et al. Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes[J]. Diabetes, 2003 Oct,52(10) :2586.
  • 4Forbes JM, Cooper ME, et al. Role of advanced glycation end products in diabetic nephropathy[J]. J Am Soc Nephrol, 2003,14(8 Suppl 3):S254.
  • 5Omoto S, Nomura S, et al. Significance of platelet-derived microparticles and activated plate lets in diabetic nephropathy[J]. Nephron, 1999,81(3):271.
  • 6Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase:potential relevance in diabetic nephropathy[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3):S221.
  • 7Ha H, Lee HB. Reactive oxygen species and matrix remodeling in diabetic kidney[J]. J Am Soc Nephrol, 2003 Aug, 14(8 Suppl 3) :S246.
  • 8Anjaneyulu M, Chopra K. Effect of Irbesartan on the Antioxidant Defence System and Nitric Oxide Release in Diabetic Rat Kidney[J]. Am J Nephrol, 2004 Sep 7,24(5) :488.
  • 9Onozato ML, Tojo A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy:effects of ACEI and ARB[J]. Kidney Int, 2002 Jan,61(1) :186.
  • 10Baricos WH, Cortez SL, el-Dahr SS, et al. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade[J].Kidney Int, 1995,47(4): 1039.

共引文献391

同被引文献113

引证文献9

二级引证文献123

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部